Deals
DuPont Investor Trian Starts Proxy Fight for Board Seats
This article is for subscribers only.
Activist investor Trian Fund Management LP made an opening bid to gain four board seats at DuPont Co., setting the stage for a potential breakup of the top U.S. chemical maker by value.
Trian nominated its co-founder and Chief Executive Officer Nelson Peltz as a DuPont director, the New York-based investment firm said yesterday in a statement. Also nominated are John H. Myers, a former CEO of GE Asset Management Inc.; Arthur B. Winkleblack, former chief financial officer at H.J. Heinz Co.; and Robert J. Zatta, acting CEO at chemicals maker Rockwood Holdings Inc.